Quarterly ResultMay 6, 2026, 04:25 PM
Medline Q1 Net Sales $7.35B; Net Income Attributable $129M
AI Summary
Medline Inc. reported net sales of $7,352 million for the first quarter of 2026, an increase from $6,644 million in the prior year period. However, net income attributable to Medline Inc. significantly decreased to $129 million from $322 million in Q1 2025. The company also noted a secondary offering in March 2026 where selling stockholders sold 86.25 million shares of Class A common stock, which reduced noncontrolling interest in Medline Holdings by approximately 3%.
Key Highlights
- Net sales for Q1 2026 increased to $7,352 million from $6,644 million in Q1 2025.
- Net income attributable to Medline Inc. for Q1 2026 was $129 million, down from $322 million in Q1 2025.
- Basic earnings per share for Q1 2026 was $0.16.
- Cash and cash equivalents rose to $2,236 million as of March 28, 2026, from $1,939 million.
- Total liabilities increased to $19,665 million as of March 28, 2026, from $19,198 million.
- A secondary offering of 86.25 million Class A common stock by selling stockholders occurred at $41.00 per share.
- The secondary offering reduced noncontrolling interest in Medline Holdings by approximately 3%.
- Long-term borrowings, less current portion, stood at $12,495 million as of March 28, 2026.